Evaluation of DHA for the Treatment of PSC

NCT00325013 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Primary Sclerosing Cholangitis
Colitis

Interventions

DRUG: Docosahexaenoic Acid (DHA)

Sponsor

Beth Israel Deaconess Medical Center

Collaborators

[object Object]